BooksTestimonialsInterviewsLibraryArticlesShop Here 

Sovaldi

Lloyd Live on Freedomizer Radio

This broadcast was live on Friday.  Discussion of Hepatitis C, Sovaldi prescription and alternatives.

Fast Forward to the 114 to begin the discussion with Lloyd.

New Current Events Podcasts with FreedomizerRadio on BlogTalkRadio

-->

$1,000-a-pill Hepatitis drug in USA sells for less than $10 in Egypt

(NaturalNews) The financial raping of America by Big Pharma has just achieved a new milestone with the impending launch of a Hepatitis C drug that costs $1,000 a pill. If you've ever wondered why U.S. health care is so unaffordable and inaccessible -- and why health insurance costs are bankrupting businesses and municipalities across the nation -- this is exactly why. The same drug that sells for $1,000 a pill in the USA -- named "Sovaldi" -- sells for just $10 in Egypt, or 1/100th the USA price.

Gilead’s New One Pill a Day Cure for Hepatitis C

By Lloyd Wright, NHC, Best Selling Author

Over the last 2 ½ years, I have had a handful of clients that were successful at getting into the Gilead Sciences phase 1, 2 and 3 trials for their new drug, Sofosbuvir, for the treatment of Hepatitis C.

Gilead Sofosbuvir At the same time I had numerous clients that were rejected for these same trials. After reviewing lab work sent to me by these people and having lengthy discussions on the phone with them, it appears that the trials were being manipulated. They chose the healthiest people for testing their drug, not just physically healthy but ones with the most positive attitudes. I suspected this all along and then on November 4, 2013, the New York Times published an article on the new drug and they wrote, in reference to the previous 100% cure pushed in 2011 with full page ads in the Los Angeles Times, constant advertising on KNX News radio, that this was a 100% cure, “There was a huge rush to treatment. But doctors now say that side effects were worse than expected, in part because the sickest patients had been excluded from the clinical trials of the drugs.” “A lot of that didn’t come to light until after the drugs were approved,” said Dr. Frain R. Edlin, an associate professor of public health and medicine at Weill Cornell Medical College. “Then it turns out they were just horrible.”.  (1)

Syndicate content